DNA sequence recognition by the indolocarbazole antitumor antibiotic AT2433-B1 and its diastereoisomer

Nucleic Acids Research

Volumn 30, Issue 8, 2002, Pages 1774-1781

  Carrasco, Carolina ^a   Facompré, Michaël ^a   Chisholm, John D ^b   Van Vranken, David L ^b   Wilson, W David ^c   Bailly, Christian ^a  

^a INSERM   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; ADENINE; ANTINEOPLASTIC ANTIBIOTIC; AT2433 B1; BIOTIN; CARBAZOLE DERIVATIVE; CYTOSINE; DEOXYRIBONUCLEASE I; DNA; DOUBLE STRANDED DNA; GUANINE; INDOLE DERIVATIVE; OLIGOMER; REBECCAMYCIN; THYMINE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRADATION KINETICS; DIASTEREOISOMER; DISSOCIATION CONSTANT; DNA FOOTPRINTING; DNA SEQUENCE; DNA STRUCTURE; DRUG DNA BINDING; DRUG DNA INTERACTION; DRUG STRUCTURE; GC RICH SEQUENCE; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RESTRICTION FRAGMENT; SURFACE PLASMON RESONANCE; THERMOREGULATION;

EID: 0037089152     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/30.8.1774     Document Type: Article

References (39)

1. Non-camptothecin topoisomerase I compounds as potential anticancer agents
2. Advances in indolo [2,3-a]carbazole chemistry: Design synthesis of protein kinase C and topoisomerase I inhibitors
3. Topoisomerase I poisons and suppressors as anticancer drugs
4. Novel antitumor indolocarbazole compound 6-N-formylamino-12,13-dihydro-1, 11-dihydroxy-13-(β-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo- [3,4-c]carbazole-5,7-(6H)-dione (NB-506): Induction of topoisomerase and mechanisms of cell line-selective cytotoxicity
5. Use of camptothecin-resistant mammalian cell lines to evaluate the role of topoisomerase I in the antiproliferative activity of the indolocarbazole, NB-506 and its topoisomerase I binding site
6. Specific inhibition of SR splicing factors phosphorylation, spliceosome assembly and splicing by the anti-tumor drug NB506
7. Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models
8. Analogs of staurosporine: Potential anticancer drugs
9. In vivo antitumor activity of a novel indolocarbazole compound, J-107088, on murine and human tumors transplanted into mice
10. Mode of action of a new indolocarbazole anticancer agent, J-107088, targeting topoisomerase I
11. Identification of breast cancer resistant protein/mitoxantrone resistant/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure
12. Indolocarbazole poisons of human topoisomerase I: Regioisomeric analogues of ED-110
13. PKC412 - A protein kinase inhibitor with a broad therapeutic potential
14. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage
15. AT2433-A1, AT2433-A2, AT2433-B1 and AT2433-B2 novel antitumor compounds produced by Actinomadura melliaura. II. Structure determination
16. AT2433-A1, AT2433-A2, AT2433-B1 and AT2433-B2, novel antitumor antibiotic compounds produced by Actinomadura malliaura
17. Regiocontrolled synthesis of the antitumor antibiotic AT2433-A1
18. A caveat in the application of the exciton chirality method to N, N-dialkyl amides. Synthesis and structural revision of AT2433-B1
19. Comparison of different footprinting methodologies for detecting binding sites for a small ligand on DNA
20. Determination of the refractive index increments of small molecules for correction of surface plasmon resonance data
21. Binding Constants
22. DNase I footprinting
23. High-resolution footprinting studies of drug-DNA complexes using chemical and enzymic probes
24. Influence of compound structure on affinity, sequence selectivity and mode of binding to DNA for unfused aromatic dications related to furamidine
25. Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino-sugar residue
26. Formaldehyde cross-linking of a 2′-aminoglucose rebeccamycin derivative to both A·T and G·C base pairs in DNA
27. DNA binding properties of the indolocarbazole antitumor drug NB-506
28. Designed enediynes: A new class of DNA-cleaving molecules with potent and selective anticancer activity
29. Chemistry and biology of natural and designed enediynes
30. Interaction of calicheamicin with duplex DNA: Role of the oligosaccharide domain and identification of multiple binding modes
31. 1-DNA complex
32. I-DNA complex
33. Esperamicins, a class of potent antitumor antibiotics: Mechanism of action
34. Minor-groove width and accessibility in B-DNA drug and protein complexes
35. 2
36. BIAcore and DNA footprinting for discovery and development of new DNA targeted therapeutics and reagents
37. Footprinting at low temperature: Evidence that ethidium and other simple intercalators can discriminate between different nucleotide sequences
38. Sequence-specificity of the binding of 9-aminoacridine- and amsacrine-4-carboxamides to DNA studied by DNase I footprinting
39. Recognition of specific sequences in DNA by a topoisomerase I inhibitor derived from the antitumor drug rebeccamycin